NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Antaros Medical AB

Antaros Medical AB

Private
MölndalHealthcare & Life Scienceshttps://antarosmedical.com/

Last Round

Buyout/LBO

Jul 15, 2025

Company Overview

Antaros Medical AB is a biotechnology company that provides imaging methodologies and clinical study design services to support pharmaceutical companies in drug development.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Imaging, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROmedical imagingclinical trial supportimaging biomarkersdrug developmentquantitative imagingbiotech servicesMRIPET/CTclinical imagingprecision medicinedrug efficacybiotech outsourcingimaging core lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Antaros Medical AB Comps

Public and private peers based on sector, stage, and business model.

Antaros Medical AB comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Antaros Medical AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBOJul 15, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Richard Olbe

Chief Executive Officer, CEO Antaros Medical US Inc.

Executive Team

Dan-Alp Lindberg

Chief Financial Officer

Executive Team

Kerstin Heurling

Chief Operating Officer

Executive Team

Antaros Medical AB Investors

Notable investors and investment history

Antaros Medical AB investors
InvestorRounds
Lauxera Capital PartnersBuyout/LBO
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Monthly visitors increased 35% MoM.

  • Jul 10, 2025

    Monthly visitors grew 120% MoM, reaching 5.5K.

View all signals

Antaros Medical AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Antaros Medical AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Antaros Medical AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersMölndal
Employee Range133
Year Founded2014
Last FundingJul 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.